Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04001413
Title Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications

oropharynx cancer

Therapies

Durvalumab

Durvalumab + MEDI0457

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Johns Hopkins University Baltimore Maryland 21287 United States Details
Mount Sinai School of Medicine, The Tisch Cancer Institute New York New York 10029 United States Details
Mount Sinai School of Medicine New York New York 10029 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field